NeoGenomics, Inc. Shareholders' Equity
NeoGenomics, Inc. (NEO) had Shareholders' Equity of $785.73 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-28
- 2026-06-30: Stockholders' Equity Attributable to Parent $785.73M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $828.76M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $836.56M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $838.29M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $785.73M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $828.76M 10-Q · filed 2026-07-28 | |
| 2025-12-31 | $836.56M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $838.29M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $854.04M 10-Q · filed 2026-07-28 | |
| 2025-03-31 | $888.27M 10-Q · filed 2026-07-28 | |
| 2024-12-31 | $902.34M 10-Q · filed 2026-07-28 | |
| 2024-09-30 | $908.21M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $915.88M 10-Q · filed 2025-10-28 | |
| 2024-03-31 | $923.41M 10-Q · filed 2025-10-28 | |
| 2023-12-31 | $941.54M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $947.43M 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $956.19M 10-Q · filed 2024-11-05 | |
| 2023-03-31 | $974.46M 10-Q · filed 2024-11-05 | |
| 2022-12-31 | $998.02M 10-K · filed 2026-02-17 | |
| 2022-09-30 | $1.01B 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $1.04B 10-Q · filed 2023-11-06 | |
| 2022-03-31 | $1.08B 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $1.11B 10-K · filed 2025-02-18 | |
| 2021-09-30 | $1.14B 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.15B 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $843.71M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $694.29M 10-K · filed 2024-02-20 | |
| 2020-09-30 | $666.36M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $654.23M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $505.04M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $507.41M 10-K · filed 2023-02-24 | |
| 2019-09-30 | $497.01M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $489.73M 10-Q · filed 2020-10-29 | |
| 2019-03-31 | $323.85M 10-Q · filed 2020-10-29 | |
| 2018-12-31 | $320.44M 10-K · filed 2022-02-25 | |
| 2018-09-30 | $303.56M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $164.21M 10-Q · filed 2019-11-13 | |
| 2018-03-31 | $171.99M 10-Q · filed 2019-11-13 | $172.54M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $171.96M 10-K · filed 2021-02-25 | $172.92M 10-K · filed 2018-03-13 |
| 2017-09-30 | $169.53M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $168.90M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $168.59M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $162.32M 10-K · filed 2020-02-28 | $163.72M 10-K · filed 2017-03-14 |
| 2016-09-30 | $200.79M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $203.63M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $206.00M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $208.52M 10-K · filed 2019-02-26 | $209.51M 10-K · filed 2016-03-15 |
| 2015-09-30 | $61.85M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $60.87M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $60.16M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $60.41M 10-K · filed 2018-03-13 | |
| 2014-09-30 | $59.06M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $23.13M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | $22.50M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $21.71M 10-K · filed 2017-03-14 | |
| 2013-09-30 | $20.33M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $19.44M 10-Q · filed 2013-08-02 | |
| 2013-03-31 | $18.83M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $9.22M 10-K · filed 2016-04-18 | |
| 2012-09-30 | $9.22M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $9.72M 10-Q/A · filed 2012-08-15 | |
| 2012-03-31 | $8.67M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $5.90M 10-K · filed 2015-03-03 | |
| 2011-09-30 | $5.36M 10-Q · filed 2011-10-25 | |
| 2011-06-30 | $5.29M 10-Q/A · filed 2011-08-01 | |
| 2010-12-31 | $3.13M 10-K · filed 2014-02-24 | |
| 2009-12-31 | $5.64M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |